U.S. High Insider Buying

Apimeds Pharmaceuticals US

Market Cap: US$20.5m

Operates as a clinical stage biopharmaceutical company in the United States.

Beeline Holdings

Market Cap: US$19.9m

Engages in the fintech mortgage lending business.

Relmada Therapeutics

Market Cap: US$19.2m

Operates as a clinical-stage biotechnology company in the United States.

Linkage Global

Market Cap: US$18.2m

Through its subsidiaries, provides cross-border e-commerce integrated services in Japan, Hong Kong, and the People’s Republic of China.

Freight Technologies

Market Cap: US$18.2m

Through its subsidiary, operates as a technology company that engages in the freight management business in the United States and Mexico.

NKGen Biotech

Market Cap: US$17.9m

A clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.

Bridgeline Digital

Market Cap: US$17.8m

Operates as a marketing technology company in the United States, Canada, and internationally.

Aspire Biopharma Holdings

Market Cap: US$17.5m

An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.

Oxbridge Re Holdings

Market Cap: US$17.2m

Through its subsidiaries, provides specialty property and casualty reinsurance solutions.

Nocopi Technologies

Market Cap: US$16.2m

Develops and markets specialty reactive inks for applications in the educational and toy products, and document and product authentication industries in North America, South America, Europe, Asia, and Australia.

Rise Gold

Market Cap: US$16.2m

Explores for mineral properties in the United States.

SeaStar Medical Holding

Market Cap: US$16.0m

A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

Glen Burnie Bancorp

Market Cap: US$15.6m

Operates as the bank holding company for The Bank of Glen Burnie that provides commercial and retail banking services to individuals, associations, partnerships, and corporations.

Ernexa Therapeutics

Market Cap: US$14.6m

A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.

ProStar Holdings

Market Cap: US$14.5m

Develops geospatial intelligence software.

Cellectar Biosciences

Market Cap: US$14.3m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Zeo ScientifiX

Market Cap: US$13.5m

A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.

MetaVia

Market Cap: US$13.2m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

Urano Energy

Market Cap: US$13.2m

A mineral exploration company, engages in acquisition and exploration conventional uranium assets in the United States and Canada.

Dolphin Entertainment

Market Cap: US$13.2m

Operates as an entertainment marketing and production company in the United States.

Cosmos Health

Market Cap: US$12.6m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.

Abpro Holdings

Market Cap: US$12.4m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.

BioCardia

Market Cap: US$12.2m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Rize Oncology

Market Cap: US$12.1m

A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.

Energy Focus

Market Cap: US$11.9m

Designs, develops, manufactures, markets, and sells energy-efficient lighting systems and controls in the United States and internationally.

Phio Pharmaceuticals

Market Cap: US$11.8m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

BetterLife Pharma

Market Cap: US$11.3m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

BluSky AI

Market Cap: US$10.6m

A modular data center company, focuses on providing artificial intelligence compute infrastructure solutions.

Mill City Ventures III

Market Cap: US$10.5m

A principal investment firm specializing investments in debt and equity securities of public and private companies to fund their operations whether its start-up, acquisition, or growth.

Perfect Moment

Market Cap: US$10.2m

Owns and operates a fashion brand that offers ski, surf, and activewear collections under the brand name of Perfect Moment in the United Kingdom, rest of Europe, the United States, and internationally.

Bimini Capital Management

Market Cap: US$10.0m

Through its subsidiaries, operates as a specialty finance company in the United States.

Socket Mobile

Market Cap: US$9.4m

Provides data capture and delivery solutions in the United States, Europe, Asia, and internationally.

AEON Biopharma

Market Cap: US$8.8m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

HCW Biologics

Market Cap: US$8.2m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

SusGlobal Energy

Market Cap: US$8.0m

Engages in acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application in Canada.

Blum Holdings

Market Cap: US$7.9m

Through its subsidiaries, engages in the retail and distribution of cannabis products in the United States.